[25-014521]NIH nhlbi laboratory of immune regulatory genomics and epigenomics requires total SEQ antibody cocktails (mixtures of antibodies conjugated to DNA oligonucleotides for the preparation of…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025P00372
- Awardee
-
Biolegend, Inc. UEI WVJUG294HEM6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,493
Award facts
- Contract value 100% obligated
- $10,492.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other scientific research products based in San Diego, California. The $10,492.50 firm-fixed-price purchase order is for the delivery of Total-Seq antibody cocktails, which are mixtures of antibodies conjugated to DNA oligonucleotides used in the preparation of multi-omic single-cell libraries. This contract supports the NHLBI's Laboratory of Immune Regulatory Genomics and Epigenomics and does not have a small business set-aside designation. Biolegend, Inc. has a history of providing specialized research materials to various NIH institutes, including for COVID-19 investigations, immune response analysis, and studies on diseases like multiple sclerosis and cancer.
Description
[25-014521]NIH nhlbi laboratory of immune regulatory genomics and epigenomics requires total SEQ antibody cocktails (mixtures of antibodies conjugated to DNA oligonucleotides for the preparation of multiomic single cell libraries) in order to add IMM
Quick answers
Who was awarded contract 75N92025P00372?
75N92025P00372 was awarded to Biolegend, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 11, 2025.
How much is contract 75N92025P00372 worth?
The government has obligated $10,493 on 75N92025P00372.
Was contract 75N92025P00372 competed?
The extent of competition for 75N92025P00372 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award